Patent details

EP3949952 Title: PHARMACEUTICAL COMPOSITION

Basic Information

Publication number:
EP3949952
PCT Application Number:
JP2020015225
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP207848888
PCT Publication Number:
WO2020204142
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL COMPOSITION
French Title of Invention:
COMPOSITION PHARMACEUTIQUE
German Title of Invention:
PHARMAZEUTISCHE ZUSAMMENSETZUNG
SPC Number:

Dates

Filing date:
02/04/2020
Grant date:
17/07/2024
EP Publication Date:
09/02/2022
PCT Publication Date:
08/10/2020
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/07/2024
EP B1 Publication Date:
17/07/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
02/04/2040
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/07/2024
 
 

Name:
Astellas Pharma Inc.
Address:
5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku Tokyo 103-8411, Japan (JP)

Inventor

1

Name:
TAKAE Seiji
Address:
Japan (JP)

2

Name:
TANAKA Ko
Address:
Japan (JP)

3

Name:
MIYAZAKI Masakazu
Address:
Japan (JP)

4

Name:
SASAKI Akihiko
Address:
Japan (JP)

Priority

Priority Number:
2019070997
Priority Date:
03/04/2019
Priority Country:
Japan (JP)

Classification

IPC classification:
A61K 9/20; A61K 47/22; A61K 47/26; A61K 47/46; A61K 31/497; A61K 9/00; A61K 9/16;

Publication

European Patent Bulletin

1

Issue number:
202429
Publication date:
17/07/2024
Description:
Grant (B1)

2

Issue number:
202429
Publication date:
17/07/2024
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/10/2025
Annual Fee Number:
6
Annual Fee Amount:
66 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages